- Home
- NCNA vs SVRE Comparison
NCNA vs SVRE Comparison
Compare NCNA & SVRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NCNA | SVRE |
|---|---|---|
| Founded | 1997 | 2014 |
| Country | United Kingdom | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5M | 6.2M |
| IPO Year | 2017 | 2021 |
Fundamental Metrics
Financial Performance| Metric | NCNA | SVRE |
|---|---|---|
| Price | $1.11 | $1.10 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 56.4K | 38.4K |
| Earning Date | 11-12-2026 | 08-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $1,756.92 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.01 | $0.55 |
| 52 Week High | $6.16 | $6.30 |
Technical Indicators
Market Signals| Indicator | NCNA | SVRE |
|---|---|---|
| Relative Strength Index (RSI) | 36.11 | 24.04 |
| Support Level | N/A | $0.62 |
| Resistance Level | $1.40 | $1.96 |
| Average True Range (ATR) | 0.09 | 0.27 |
| MACD | -0.02 | -0.09 |
| Stochastic Oscillator | 28.97 | 3.30 |
Price Performance
Historical ComparisonAbout NCNA NuCana plc
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States and the United Kingdom.
About SVRE SaverOne 2014 Ltd.
Saverone 2014 Ltd is engaged in the design, development, and commercialization of transportation and safety solutions, designed to prevent car accidents based on its patented technology of detecting, analyzing, and locating cellular phone radio frequency, or RF signals. The company is developing two product lines: the first is an In-Cabin Driver Distraction Prevention Solution (known as SaverOne system), or DDPS; and the second is an Advanced Driver-Assistance System, or ADAS, product that detects vulnerable road users, or VRUs, and provides a warning to the vehicle regarding potential collision. Geographically, Saverone generates maximum revenue from Europe and the rest from Israel.